[Effects of the proteinase inhibitor trasylol on cardio-pulmonary and metabolic parameters].
D000136:Acid-Base Equilibrium; D000328:Adult; D007611:Aprotinin / Q000494:pharmacology*; D001481:Basal Metabolism / Q000187:drug effects*; D002245:Carbon Dioxide / Q000097:blood; D002254:Carbonates / Q000097:blood; D002319:Cardiovascular System / Q000187:drug effects*; D004562:Electrocardiography; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007773:Lactates / Q000097:blood; D008168:Lung / Q000187:drug effects; D008297:Male; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D012119:Respiration / Q000187:drug effects; D013147:Spirometry
D002254:Carbonates; D007773:Lactates; D002245:Carbon Dioxide; D007611:Aprotinin; D010100:Oxygen
Arbeitsuntersuchungen über die Wirkung des Proteinasen-Inhibitors Trasylol auf kardio-pulmonale und Stoffwechselparameter.